[go: up one dir, main page]

PL3011312T3 - Sposoby analizy kompozycji cysteaminy - Google Patents

Sposoby analizy kompozycji cysteaminy

Info

Publication number
PL3011312T3
PL3011312T3 PL14814315.9T PL14814315T PL3011312T3 PL 3011312 T3 PL3011312 T3 PL 3011312T3 PL 14814315 T PL14814315 T PL 14814315T PL 3011312 T3 PL3011312 T3 PL 3011312T3
Authority
PL
Poland
Prior art keywords
analyzing
methods
cysteamine compositions
cysteamine
compositions
Prior art date
Application number
PL14814315.9T
Other languages
English (en)
Inventor
Kathlene Powell
Ramesh Muttavarapu
Original Assignee
Horizon Therapeutics Ireland Dac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horizon Therapeutics Ireland Dac filed Critical Horizon Therapeutics Ireland Dac
Publication of PL3011312T3 publication Critical patent/PL3011312T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/74Optical detectors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32Bonded phase chromatography
    • B01D15/325Reversed phase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/33Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/16Injection
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8818Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/17Nitrogen containing
    • Y10T436/173845Amine and quaternary ammonium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
PL14814315.9T 2013-06-17 2014-06-17 Sposoby analizy kompozycji cysteaminy PL3011312T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361835987P 2013-06-17 2013-06-17
PCT/US2014/042616 WO2014204887A1 (en) 2013-06-17 2014-06-17 Methods for analyzing cysteamine compositions

Publications (1)

Publication Number Publication Date
PL3011312T3 true PL3011312T3 (pl) 2023-04-11

Family

ID=52105169

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14814315.9T PL3011312T3 (pl) 2013-06-17 2014-06-17 Sposoby analizy kompozycji cysteaminy

Country Status (11)

Country Link
US (3) US9435785B2 (pl)
EP (1) EP3011312B8 (pl)
JP (1) JP6518658B2 (pl)
AR (1) AR096629A1 (pl)
CA (1) CA2914674C (pl)
ES (1) ES2931310T3 (pl)
IL (1) IL242843B (pl)
MX (1) MX370192B (pl)
PL (1) PL3011312T3 (pl)
TW (1) TWI659209B (pl)
WO (1) WO2014204887A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109633055B (zh) * 2018-12-29 2023-01-13 贵州长生药业有限责任公司 杀菌止痒洗剂多成分含量测定方法
US11782040B1 (en) * 2023-05-12 2023-10-10 Michele Glinn Cannabis potency testing method

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6050186B2 (ja) * 1980-07-15 1985-11-07 三井東圧化学株式会社 2−メルカプトエチルアミンハロゲン化水素酸塩類の製造法
US5011608A (en) * 1988-11-18 1991-04-30 Dragana Damjanovic Biogenic amine assay using HPLC-ECD
US5256362A (en) * 1989-07-14 1993-10-26 Nippon Shokubai Co., Ltd. Method for production of granular cysteamine hydrochloride
WO1997014711A1 (en) * 1995-10-19 1997-04-24 Receptagen Corporation Vitamin b12 receptor modulating agents and methods related thereto
US6548307B2 (en) * 2000-02-14 2003-04-15 Pfizer Inc. Determination of logP coefficients via a RP-HPLC column
US7947742B2 (en) * 2002-06-28 2011-05-24 Civitas Therapeutics, Inc. Inhalable epinephrine
US20050250838A1 (en) * 2004-05-04 2005-11-10 Challapalli Prasad V Formulation for sustained delivery
WO2006134173A2 (en) * 2005-06-17 2006-12-21 Novo Nordisk Health Care Ag Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine
MX382184B (es) * 2006-01-27 2025-03-13 Univ California Cisteamina recubierta entericamente, cistamina y derivados de ellas.
US20070193886A1 (en) * 2006-02-02 2007-08-23 Ian Acworth Detection methods and devices
SG138487A1 (en) * 2006-06-19 2008-01-28 Singapore Polytechnic Method for catalysing a fusion polypeptide undergoing a cleavage reaction
AU2007317561A1 (en) * 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
AU2007338210B2 (en) * 2006-12-22 2013-01-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of ophthalmic drugs
US20080206883A1 (en) * 2007-02-26 2008-08-28 Cody Laboratories, Inc. Hplc method for separation and detection of hydromorphone and related opioid pharmacophores
JP2010133807A (ja) * 2008-12-03 2010-06-17 Dainippon Sumitomo Pharma Co Ltd 錠剤の粉砕方法およびこれをもちいた錠剤成分の分析方法
ES2625125T3 (es) 2009-08-11 2017-07-18 Biocon Limited Procesos cromatográficos
CA2732440C (en) * 2011-02-23 2017-10-31 Universite Laval Cystamine analogues for the treatment of parkinson`s disease
CN103018359B (zh) 2012-11-30 2014-06-11 华南理工大学 一种测定食品或蔬菜中草酸含量的方法
AR096628A1 (es) * 2013-06-17 2016-01-20 Raptor Pharmaceuticals Inc Formulación en perlas de cisteamina de liberación retardada y métodos de preparación y uso de ella

Also Published As

Publication number Publication date
CA2914674C (en) 2019-08-27
JP6518658B2 (ja) 2019-05-22
EP3011312B1 (en) 2022-09-28
TW201534920A (zh) 2015-09-16
US20180292366A1 (en) 2018-10-11
JP2016523364A (ja) 2016-08-08
IL242843B (en) 2019-01-31
ES2931310T3 (es) 2022-12-28
MX370192B (es) 2019-12-04
US20160341706A1 (en) 2016-11-24
EP3011312B8 (en) 2022-11-02
WO2014204887A1 (en) 2014-12-24
US9435785B2 (en) 2016-09-06
EP3011312A4 (en) 2017-01-25
CA2914674A1 (en) 2014-12-24
EP3011312A1 (en) 2016-04-27
US20150056712A1 (en) 2015-02-26
TWI659209B (zh) 2019-05-11
MX2015017413A (es) 2016-06-21
AR096629A1 (es) 2016-01-20
HK1224012A1 (en) 2017-08-11

Similar Documents

Publication Publication Date Title
PL3065569T4 (pl) Kompozycja
GB201304662D0 (en) Compositions
PT3024484T (pt) Composições de anticorpo estabilizadas
IL244191A0 (en) The compositions for the analysis of the interaction between RNA and chromatin, and their uses
HUE044039T2 (hu) Biokatalitikus készítmény
GB201313615D0 (en) Compositions
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
GB201318489D0 (en) Composition
GB201319540D0 (en) Composition
GB201320919D0 (en) Composition
GB201317388D0 (en) Composition
SG11201601239PA (en) Program for program editing
GB201320303D0 (en) Composition
GB201319538D0 (en) Composition
GB201306984D0 (en) Composition
GB201322772D0 (en) Composition
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
ZA201505650B (en) New compositions
GB201320962D0 (en) Compositions
GB201420672D0 (en) Composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
IL242843B (en) Methods for analyzing cystamine preparations
GB201318394D0 (en) Composition